| Memorial Hospital Of Converse County | |
|
111 S 5th St Douglas WY 82633-2434 | |
| (307) 358-2122 | |
| (307) 358-9216 |
| Full Name | Memorial Hospital Of Converse County |
|---|---|
| Speciality | General Practice |
| Location | 111 S 5th St, Douglas, Wyoming |
| Authorized Official Name and Position | Curt Dugger (CFO) |
| Authorized Official Contact | 3073582122 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Memorial Hospital Of Converse County Po Box 1450 Douglas WY 82633-1450 Ph: (307) 358-2122 | Memorial Hospital Of Converse County 111 S 5th St Douglas WY 82633-2434 Ph: (307) 358-2122 |
| NPI Number | 1356496491 |
|---|---|
| Provider Enumeration Date | 01/25/2007 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 2264340843 |
|---|---|
| Medicare Enrollment ID | O20031203000672 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356496491 | NPI | - | NPPES |
| 00946001 | Other | WY | BLUE CROSS WY PHYS GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | (Wyoming) | Primary |
| Provider Name | Warren A Birch |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1467431361 PECOS PAC ID: 6507779634 Enrollment ID: I20031106000105 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Tanda E Hicks |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053312504 PECOS PAC ID: 6901891860 Enrollment ID: I20040419001421 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Twyla M Thalken |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306946611 PECOS PAC ID: 5991791410 Enrollment ID: I20040421001056 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | John P Thalken |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912007212 PECOS PAC ID: 6901893361 Enrollment ID: I20040428000007 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Jonathan P Binder |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1841214954 PECOS PAC ID: 0941291405 Enrollment ID: I20040521001379 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Ryan T Clifford |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295773505 PECOS PAC ID: 7113810557 Enrollment ID: I20040614001462 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Joe K Schoeber |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1740233071 PECOS PAC ID: 6709775075 Enrollment ID: I20040623000332 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Mark G Murphy |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1134187008 PECOS PAC ID: 6002885340 Enrollment ID: I20041004000144 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Angelo Mario Santiago |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1598792483 PECOS PAC ID: 0749249860 Enrollment ID: I20041006000204 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Patrick A Robertson |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1194715037 PECOS PAC ID: 5193623072 Enrollment ID: I20041006000474 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Sean E Beyer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700809209 PECOS PAC ID: 6305805854 Enrollment ID: I20041008000992 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Loren B Thiel |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1063503514 PECOS PAC ID: 0042205718 Enrollment ID: I20041108000211 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Mohammed Majeed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598854671 PECOS PAC ID: 2567413164 Enrollment ID: I20050201000423 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Joseph E Mickelson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467448043 PECOS PAC ID: 2668365008 Enrollment ID: I20050822000307 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | William L White |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1457461774 PECOS PAC ID: 7214952282 Enrollment ID: I20051008000194 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Patrick A Yost |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1932122793 PECOS PAC ID: 4688693815 Enrollment ID: I20051117000133 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Derek H Gilbert |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1477665925 PECOS PAC ID: 6305815317 Enrollment ID: I20060302000595 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Jonathan L Grosdidier |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1992808398 PECOS PAC ID: 0749240810 Enrollment ID: I20060314000095 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Sherrill A Fox |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1124034566 PECOS PAC ID: 0345244851 Enrollment ID: I20060913000619 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Charles R Woodruff |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1700956877 PECOS PAC ID: 6709786965 Enrollment ID: I20070117000510 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Troy E Votruba |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1477576874 PECOS PAC ID: 5395842389 Enrollment ID: I20070828000667 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Julie A Novick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467525519 PECOS PAC ID: 4284727934 Enrollment ID: I20070911000537 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Deanne J Johnson Engle |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346433554 PECOS PAC ID: 2769576800 Enrollment ID: I20070919000800 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Razi Saydjari |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1902880628 PECOS PAC ID: 4385622034 Enrollment ID: I20080905000032 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Craig S Capron |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1932118189 PECOS PAC ID: 8224199898 Enrollment ID: I20081202000358 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Lonnie A Teague |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1336311463 PECOS PAC ID: 9537220801 Enrollment ID: I20081204000589 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Geoffrey Sherman |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1275787087 PECOS PAC ID: 3971665001 Enrollment ID: I20081223000464 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Christopher C Brown |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1376569202 PECOS PAC ID: 5597779033 Enrollment ID: I20090403000068 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Roberto Fars |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1417053836 PECOS PAC ID: 5496737926 Enrollment ID: I20090608000176 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Dennis S Yutani |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1568564128 PECOS PAC ID: 6901863232 Enrollment ID: I20100121000437 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Brehan A Newell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922335579 PECOS PAC ID: 0840332110 Enrollment ID: I20100126000750 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Brian S Retherford |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1134183080 PECOS PAC ID: 1759329634 Enrollment ID: I20101018001309 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Steven J Beer |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1588633291 PECOS PAC ID: 4688745813 Enrollment ID: I20101104000817 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Ethan T Oconnell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1306097928 PECOS PAC ID: 7911193081 Enrollment ID: I20101201000683 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Karen A Fagin |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1205026994 PECOS PAC ID: 4385540228 Enrollment ID: I20111018000212 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Eric Schubert |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1275594467 PECOS PAC ID: 6901808054 Enrollment ID: I20111116000964 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Michael Ryan Johnson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1336419969 PECOS PAC ID: 1557522687 Enrollment ID: I20120926000809 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Peggy D Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245455286 PECOS PAC ID: 0143479923 Enrollment ID: I20121011000537 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Kenneth John Whipple |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1922040807 PECOS PAC ID: 0345331591 Enrollment ID: I20130924000377 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Timothy E Olson |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699099143 PECOS PAC ID: 3678707189 Enrollment ID: I20131015001999 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Mark S Campbell |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1770571432 PECOS PAC ID: 6800893678 Enrollment ID: I20131203002085 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | David Fairbanks |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1700989969 PECOS PAC ID: 8325028830 Enrollment ID: I20140129000776 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Douglas Wesley White |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1538140322 PECOS PAC ID: 7012055973 Enrollment ID: I20140214001636 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Ryan S Benson |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1023308491 PECOS PAC ID: 9234384041 Enrollment ID: I20140708001799 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Kathryn A Skuza |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1780698332 PECOS PAC ID: 0648171660 Enrollment ID: I20140724001151 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | David B Tarullo |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1295034874 PECOS PAC ID: 1850519653 Enrollment ID: I20140819002819 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Francis A Lansang |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346391927 PECOS PAC ID: 3678672292 Enrollment ID: I20141021003241 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Philip Najm |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1336341312 PECOS PAC ID: 6204904725 Enrollment ID: I20150101000006 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Casey M Starks |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1316205677 PECOS PAC ID: 7517100456 Enrollment ID: I20150917002771 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Kerry K Fischer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437522125 PECOS PAC ID: 7012217557 Enrollment ID: I20151204001554 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Ashley M Littleton |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1538332820 PECOS PAC ID: 0648343855 Enrollment ID: I20160223001436 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Sarah L Frank |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619330149 PECOS PAC ID: 3173812542 Enrollment ID: I20160525001912 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Keith T Borg |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1316042518 PECOS PAC ID: 6901798578 Enrollment ID: I20161027000905 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Marisa Laurora |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1811948102 PECOS PAC ID: 4587624937 Enrollment ID: I20161103001809 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Frederick R Freeman |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1720054646 PECOS PAC ID: 5698784429 Enrollment ID: I20161117002079 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Jared A Hall |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1861745077 PECOS PAC ID: 6507182516 Enrollment ID: I20161219001563 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Melissa R Quinn-bulkley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811447956 PECOS PAC ID: 7012298490 Enrollment ID: I20161222001047 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | David C Kasarda |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1568437911 PECOS PAC ID: 1759377070 Enrollment ID: I20170125002732 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Temberly Long |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225406085 PECOS PAC ID: 3678858834 Enrollment ID: I20170330001316 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Burk T Young |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1366490963 PECOS PAC ID: 4183666084 Enrollment ID: I20170829003779 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Stephen J Pecevich |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1194102384 PECOS PAC ID: 6800151366 Enrollment ID: I20180604001732 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Regg A Hagge |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1902850779 PECOS PAC ID: 3375444508 Enrollment ID: I20180626001331 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Ashley E Ullrich |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1366837627 PECOS PAC ID: 6608162714 Enrollment ID: I20181113003122 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | James Bruce Odone |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1104005172 PECOS PAC ID: 2668609926 Enrollment ID: I20181120001891 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Aaron Mcclellan |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1881016822 PECOS PAC ID: 6204067903 Enrollment ID: I20190204001643 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Michelle L Neice |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770926909 PECOS PAC ID: 7416191861 Enrollment ID: I20190318002639 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Jennifer Keller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639586209 PECOS PAC ID: 4981944923 Enrollment ID: I20190328003023 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Toni Marie Harms |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639643216 PECOS PAC ID: 3678815768 Enrollment ID: I20190418002513 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Nathan Cook |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1912355082 PECOS PAC ID: 0941595128 Enrollment ID: I20190723002328 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Sandra Susanne Gebhart |
|---|---|
| Provider Type | Practitioner - Hand Surgery |
| Provider Identifiers | NPI Number: 1164865796 PECOS PAC ID: 1759683527 Enrollment ID: I20190916000544 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Sven Markus Hochheimer |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1629089685 PECOS PAC ID: 1557514882 Enrollment ID: I20190917002518 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Stefan Yakel |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1245678085 PECOS PAC ID: 6608106489 Enrollment ID: I20190920000614 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Jennifer Ella Wagy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861042392 PECOS PAC ID: 2567896061 Enrollment ID: I20191216001545 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Amanda K Dykes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902447477 PECOS PAC ID: 9032543749 Enrollment ID: I20200103001902 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Mark C Drumhiller |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1629323837 PECOS PAC ID: 3173771912 Enrollment ID: I20200206000541 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Sara M Thronburg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225662216 PECOS PAC ID: 0840620951 Enrollment ID: I20200413003035 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Stefani L. Bissonette |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1407200660 PECOS PAC ID: 8527350495 Enrollment ID: I20200805000423 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Julie Lynn Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154912012 PECOS PAC ID: 4688082753 Enrollment ID: I20210410000048 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | David L Ekman |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1821344490 PECOS PAC ID: 2365754025 Enrollment ID: I20210414000447 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Ryker M Kiel |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1528450327 PECOS PAC ID: 9830434133 Enrollment ID: I20210506001684 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Christopher S Johnson |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1760532634 PECOS PAC ID: 3375629769 Enrollment ID: I20211102002172 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Carene Emmett Weinand |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407514573 PECOS PAC ID: 7911390695 Enrollment ID: I20220201001061 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | John A Sielatycki |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1629335658 PECOS PAC ID: 2961705546 Enrollment ID: I20220224001550 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Trevor W Bush |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1942380431 PECOS PAC ID: 1658564463 Enrollment ID: I20220228001980 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Mark D Talmage |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1114038403 PECOS PAC ID: 7810989365 Enrollment ID: I20220228002596 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Kyle Sokol |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699087239 PECOS PAC ID: 4688988314 Enrollment ID: I20220420001452 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Mansoor Ahmad |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1639583321 PECOS PAC ID: 2365747862 Enrollment ID: I20220620001088 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Kayla Whitson |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1700349040 PECOS PAC ID: 8628307733 Enrollment ID: I20220809004038 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Keith L Murdock |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1326305509 PECOS PAC ID: 6901112614 Enrollment ID: I20220818002955 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Yousuf Ahmed |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1609286590 PECOS PAC ID: 1254633605 Enrollment ID: I20221026000302 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Joseph Gutman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780633875 PECOS PAC ID: 9234298027 Enrollment ID: I20221026001414 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Lisa A Flora |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1821059718 PECOS PAC ID: 3577573500 Enrollment ID: I20221109001670 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Nicolette C Strand |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013484187 PECOS PAC ID: 9335472992 Enrollment ID: I20221114001987 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Brendon Gelford |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1013992890 PECOS PAC ID: 0941389514 Enrollment ID: I20230103000275 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Julie A Query |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1275730418 PECOS PAC ID: 5294914826 Enrollment ID: I20230118002838 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Johnathon A Berry |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1801091806 PECOS PAC ID: 6406039130 Enrollment ID: I20230222000694 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Robert Redwood |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1639457740 PECOS PAC ID: 7416181508 Enrollment ID: I20230327001840 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Kenneth Rapp |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1134534548 PECOS PAC ID: 2264700863 Enrollment ID: I20230412000193 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Weldon Allen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1790306843 PECOS PAC ID: 2163803339 Enrollment ID: I20230421001902 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Samuel W Hoppe |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1598147274 PECOS PAC ID: 6709196181 Enrollment ID: I20230517002104 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Mitchel Cameron Faulkner |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1851911663 PECOS PAC ID: 4486035979 Enrollment ID: I20230526002411 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Ryan T Burke |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1588835722 PECOS PAC ID: 3971671140 Enrollment ID: I20230620000799 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Wendy L Monrad |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1134186810 PECOS PAC ID: 3971576943 Enrollment ID: I20230824003649 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Dustin Ross Mayne |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1780045427 PECOS PAC ID: 3375906191 Enrollment ID: I20230828001106 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Scott M Sundheim |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1972542181 PECOS PAC ID: 8426025511 Enrollment ID: I20231013002911 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Danielle Clarke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861180473 PECOS PAC ID: 5597109454 Enrollment ID: I20240219002626 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
| Provider Name | Marvin Couch |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1023031861 PECOS PAC ID: 1153352166 Enrollment ID: I20240226001367 |
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
News Archive
Abbott today announced that its wholly-owned subsidiary, Amber Acquisition Inc., has commenced its cash tender offer for all outstanding shares of common stock of Facet Biotech Corporation at a price of $27 per share.
Asbestos that is linked to lung cancer called mesothelioma, is still present in more than one million Australian homes, offices and schools according to reports. And the problem is "compounded by poor community awareness and a disjointed approach from the three levels of government."
The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research - for the second time within only a few weeks.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 7 days ago
High Country Behavioral Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1841 Madora Ave, Douglas, WY 82633 Phone: 307-358-2846 Fax: 307-789-4225 | |
High Country Behavioral Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1841 Madora Ave, Douglas, WY 82633 Phone: 307-358-2846 Fax: 307-358-1144 | |
Trailhead Inpatient Services, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 S 5th St, Douglas, WY 82633 Phone: 307-358-2122 Fax: 800-305-3233 | |
Douglas Med Spa Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 119 N 3rd St, Douglas, WY 82633 Phone: 307-358-5244 | |
Banner Health Physicians West Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 S 5th St, Douglas, WY 82633 Phone: 307-358-4350 Fax: 307-322-3861 | |
Douglas Medical Skincare & Health Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 119 N 3rd St, Douglas, WY 82633 Phone: 307-358-5244 |